Literature DB >> 28314970

[Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?]

M Burger1.   

Abstract

BACKGROUND: Metastasis is a common event in renal cell carcinoma. Surgical resection of metastases may be feasible in two scenarios: aiming at palliation, which may be feasible due to reduced radiosensitivity of renal cell cancer, and aiming at prolonging survival, which may be feasible given the rather good prognosis of some patterns of metastasis.
OBJECTIVE: This review intends to reflect on current evidence for surgical resection of metastases in both scenarios. The literature was searched in PubMed and respective guidelines were reviewed. RESULTS AND
CONCLUSIONS: Palliative resection is mainly feasible to control symptoms like spinal compression; adjuvant radiation is advisable. Resection is markedly feasible, however, for improvement of cancer-specific survival in probably all resectable patterns of metastasis-solitary, multiple, syn- and metachronous, and in all organs-provided complete resection can be achieved. A fairly good prognosis is seen in solitary pulmonary metastasis without concomitant hilar or mediastinal lymph node metastasis and a metachronous appearance following long recurrence-free survival after tumor nephrectomy; complete resection may be considered curative in certain cases. Neo- or adjuvant medical therapy or radiation is not established. In cases lacking complete resectability, stereotactic radiation may be considered as an alternative.

Entities:  

Keywords:  Metastasectomy; Metastasis; Palliative care; Radiotherapy, adjuvant; Resection, palliative

Mesh:

Year:  2017        PMID: 28314970     DOI: 10.1007/s00120-017-0357-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  31 in total

1.  Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

Authors:  Hans-Stefan Hofmann; Heinz Neef; Katharina Krohe; Petko Andreev; Rolf-Edgar Silber
Journal:  Eur Urol       Date:  2005-03-20       Impact factor: 20.096

2.  Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma.

Authors:  David W G Langerhuizen; Stein J Janssen; Quirine M J van der Vliet; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón
Journal:  J Surg Oncol       Date:  2016-05-09       Impact factor: 3.454

3.  Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach.

Authors:  Raphael Benhaim; Elie Oussoultzoglou; Yaser Saeedi; Pascal Mouracade; Philippe Bachellier; Hervé Lang
Journal:  Urology       Date:  2015-01       Impact factor: 2.649

4.  A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer.

Authors:  Ioannis Hatzaras; Ana L Gleisner; Carlo Pulitano; Charbel Sandroussi; Kenzo Hirose; Omar Hyder; Christopher L Wolfgang; Luca Aldrighetti; Michael Crawford; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2012-05-31       Impact factor: 3.647

5.  Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.

Authors:  Matteo Santoni; Alessandro Conti; Stefano Partelli; Camillo Porta; Cora N Sternberg; Giuseppe Procopio; Sergio Bracarda; Umberto Basso; Ugo De Giorgi; Lisa Derosa; Mimma Rizzo; Cinzia Ortega; Francesco Massari; Roberto Iacovelli; Michele Milella; Giuseppe Di Lorenzo; Sebastiano Buti; Linda Cerbone; Luciano Burattini; Rodolfo Montironi; Daniele Santini; Massimo Falconi; Stefano Cascinu
Journal:  Ann Surg Oncol       Date:  2014-12-04       Impact factor: 5.344

6.  Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri
Journal:  Eur Urol       Date:  2014-06-13       Impact factor: 20.096

7.  Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma.

Authors:  Sarah P Psutka; John C Cheville; Brian A Costello; Suzanne B Stewart-Merrill; Christine M Lohse; Bradley C Leibovich; Stephen A Boorjian; R Houston Thompson
Journal:  Urology       Date:  2016-07-21       Impact factor: 2.649

8.  Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.

Authors:  Christopher D Jakubowski; Emily A Vertosick; Brian R Untch; Daniel Sjoberg; Elizabeth Wei; Frank L Palmer; Snehal G Patel; Robert J Downey; Vivian E Strong; Paul Russo
Journal:  J Surg Oncol       Date:  2016-06-23       Impact factor: 3.454

Review 9.  Radiotherapy for renal-cell carcinoma.

Authors:  Gert De Meerleer; Vincent Khoo; Bernard Escudier; Steven Joniau; Alberto Bossi; Piet Ost; Alberto Briganti; Valérie Fonteyne; Marco Van Vulpen; Nicolaas Lumen; Martin Spahn; Marc Mareel
Journal:  Lancet Oncol       Date:  2014-04       Impact factor: 41.316

10.  Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.

Authors:  Satoshi Kato; Hideki Murakami; Satoru Demura; Koshi Nambu; Yoshiyasu Fujimaki; Katsuhito Yoshioka; Norio Kawahara; Katsuro Tomita; Hiroyuki Tsuchiya
Journal:  J Surg Oncol       Date:  2016-02-05       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.